UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena

European journal of pharmaceutics and biopharmaceutics, 2024-10, Vol.203, p.114457, Article 114457

2024

Volltextzugriff (PDF)

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Volltextzugriff (PDF)

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Virology (New York, N.Y.), 2016-12, Vol.499, p.288-297

2016

Volltextzugriff (PDF)

Coronavirus vaccine-associated lung immunopathology-what is the significance?

Microbes and infection, 2020-10, Vol.22 (9), p.403-404

2020

Volltextzugriff (PDF)

Respiratory Syncytial Virus: Reverse Genetics and Vaccine Strategies

Virology, 2002-05, Vol.296 (2), p.204-211

2002

Volltextzugriff (PDF)

Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection

Journal of allergy and clinical immunology, 2012-11, Vol.130 (5), p.1187-1196.e5

2012

Volltextzugriff (PDF)

CD8+ T cell immunity against human respiratory syncytial virus

Vaccine, 2014-10, Vol.32 (46), p.6130-6137

2014

Volltextzugriff (PDF)

A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection

Antiviral research, 2019-05, Vol.165, p.11-22

2019

Volltextzugriff (PDF)

Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus

Virology (New York, N.Y.), 2024-09, Vol.597, p.110127, Article 110127

2024

Volltextzugriff (PDF)

Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging

Journal of virological methods, 2019-01, Vol.263, p.88-95

2019

Volltextzugriff (PDF)

Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model

Virology (New York, N.Y.), 2020-11, Vol.550, p.21-26

2020

Volltextzugriff (PDF)

Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies

Immunity (Cambridge, Mass.), 2024-07, Vol.57 (7), p.1681-1695.e4

2024

Volltextzugriff (PDF)

Rapid replacement of human respiratory syncytial virus A with the ON1 genotype having 72 nucleotide duplication in G gene

Infection, genetics and evolution, 2014-08, Vol.26, p.103-112

2014

Volltextzugriff (PDF)

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model

Vaccine, 2007-08, Vol.25 (33), p.6211-6223

2007

Volltextzugriff (PDF)

A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus

Antiviral research, 2017-08, Vol.144, p.57-69

2017

Volltextzugriff (PDF)

Limitations of Foxp3+ Treg depletion following viral infection in DEREG mice

Journal of immunological methods, 2014-04, Vol.406, p.58-65

2014

Volltextzugriff (PDF)

Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice

Journal of allergy and clinical immunology, 2009, Vol.123 (1), p.138-145.e5

2009

Volltextzugriff (PDF)

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity

Vaccine, 2009-05, Vol.27 (23), p.3045-3052

2009

Volltextzugriff (PDF)

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease

Antiviral research, 2014-04, Vol.104, p.1-6

2014

Volltextzugriff (PDF)

Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice

Antiviral research, 2014-04, Vol.104, p.110-117

2014

Volltextzugriff (PDF)

Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3

Pharmacological research, 2016-09, Vol.111, p.804-814

2016

Volltextzugriff (PDF)

Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses

Vaccine, 2009-09, Vol.27 (40), p.5460-5471

2009

Volltextzugriff (PDF)

Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses

Vaccine, 2006-08, Vol.24 (33), p.6018-6027

2006

Volltextzugriff (PDF)

RSV fusion (F) protein DNA vaccine provides partial protection against viral infection

Virus research, 2009-10, Vol.145 (1), p.39-47

2009

Volltextzugriff (PDF)

Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves

Vaccine, 2010-05, Vol.28 (22), p.3784-3792

2010

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Aktive Filter

ThemaRespiratory Syncytial Virus

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(366)
Mit Volltextzugriff
(374)

Publikationsform

Artikel
(375)

Sprache

Englisch
(374)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(337)
Life Sciences & Biomedicine
(336)
Humans
(250)
Animals
(189)
Immunology
(139)
Biological And Medical Sciences
(137)
Respiratory Syncytial Viruses - Immunology
(124)
Virology
(118)
Female
(117)
Respiratory Syncytial Virus Infections - Immunology
(117)
Infant
(96)
Microbiology
(88)
Fundamental And Applied Biological Sciences. Psychology
(84)
Cattle
(81)
Male
(80)
Medical Sciences
(75)
Infectious Diseases
(73)
Mice
(66)
Bovine Respiratory Syncytial Virus
(65)
Respiratory Syncytial Virus Infections - Virology
(63)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Coronavirus vaccine-associated lung immunopathology-what is the significance?

Respiratory Syncytial Virus: Reverse Genetics and Vaccine Strategies

Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection

CD8+ T cell immunity against human respiratory syncytial virus

A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection

Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus

Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging

Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model

Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies

Rapid replacement of human respiratory syncytial virus A with the ON1 genotype having 72 nucleotide duplication in G gene

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model

A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus

Limitations of Foxp3+ Treg depletion following viral infection in DEREG mice

Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease

Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice

Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3

Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses

Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses

RSV fusion (F) protein DNA vaccine provides partial protection against viral infection

Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves

Aktive Filter

Suchergebnisse filtern